Press release
PolyPeptide Group today announced the appointment of Dr. Raymond De Vré as its new Chief Executive Officer. He will succeed Jane Salik who has decided to concentrate on her role on the Board of Directors after 15 very successful years as CEO. Raymond De Vré will join PolyPeptide Group as CEO elect on 1 April 2021 and will work alongside Jane Salik during a transition period prior to taking up his role as CEO over the course of the summer. Jane Salik will remain a member of the Executive Committee until the summer of 2021, after which she will continue to focus on her role on the Board of Directors.
